Historical source coverage

2019, page 2

342 selected records with a cited source date in 2019, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2019 by record type

3 types

July 2019

34 records on this page

Literature metadata · Emideltide

Radioimmunoassay of DSIP-like material in rat brain.

PubMed lists PMID 318193 in Brain research bulletin as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1978 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

Entry of DSIP peptides into dog CSF: role of physicochemical and pharmacokinetic parameters.

PubMed lists PMID 3768731 in Brain research bulletin as Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1986-08 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

DSIP-like immunoreactivity in the developing rat brain.

PubMed lists PMID 6895711 in Brain research bulletin as Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Immunological and virological study of enfuvirtide-treated HIV-positive patients.

PubMed lists PMID 15280778 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004-08-20 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.

PubMed lists PMID 15316339 in AIDS (London, England) as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2004-09-03 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Albiglutide

Albiglutide for the treatment of type 2 diabetes mellitus.

PubMed lists PMID 28085780 in The Nurse practitioner as Journal Article, with publication-date metadata of 2017-02-12 (day precision). PeptideScanner associated the retained record with the identity slug albiglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

The role of dalbavancin in skin and soft tissue infections.

PubMed lists PMID 29298166 in Current opinion in infectious diseases as Journal Article, Review, with publication-date metadata of 2018-04 (month precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.

PubMed lists PMID 8838703 in AIDS (London, England) as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 1996-02 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT01896232

PeptideScanner retained ClinicalTrials.gov record NCT01896232 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-18, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Cerebrolysin

The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.

PubMed lists PMID 24730284 in Journal of nanoscience and nanotechnology as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord.

PubMed lists PMID 7531902 in Urology as Clinical Trial, Journal Article, with publication-date metadata of 1995-02 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the parave…

PubMed lists PMID 10218787 in Neuroscience as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

DSIP occurs in free form in mammalian plasma, human CSF and urine.

PubMed lists PMID 6549071 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-11 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

DSIP-like material in brain parts of rats running a complex maze.

PubMed lists PMID 6549074 in Physiology & behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-09 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

Permeability of blood-brain barrier to DSIP peptides.

PubMed lists PMID 6895670 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

Radioimmunoassay of DSIP-like material in human blood: possible protein binding.

PubMed lists PMID 6895671 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

Differential penetration of DSIP peptides into rat brain.

PubMed lists PMID 6897680 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1982-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Histrelin

Characterization of the solution degradation products of histrelin, a gonadotropin releasing hormone (LH/RH) agonist.

PubMed lists PMID 2051345 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1991-03 (month precision). PeptideScanner associated the retained record with the identity slug histrelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT02833857

PeptideScanner retained ClinicalTrials.gov record NCT02833857 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-07-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Gonadorelin

The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analy…

PubMed lists PMID 6752326 in The Journal of endocrinology as Comparative Study, Journal Article, with publication-date metadata of 1982-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Ipamorelin

PubMed record PMID 10828840

PeptideScanner retained PubMed bibliographic metadata for PMID 10828840 at 2026-07-30T20:50:07.370Z. PubMed recorded a metadata revision date of 2019-07-09 and an Entrez history date of 2000-06-01. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Nafarelin

On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.

PubMed lists PMID 1533376 in Fertility and sterility as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

A comparison of nafarelin acetate and danazol in the treatment of endometriosis.

PubMed lists PMID 2140996 in Fertility and sterility as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1990-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.

PubMed lists PMID 9389816 in Fertility and sterility as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1997-11 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Melanotan II

Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.

PubMed lists PMID 8637402 in Life sciences as Clinical Trial, Clinical Trial, Phase I, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1996 (year precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-2

Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells.

PubMed lists PMID 9096259 in Life sciences as Comparative Study, Journal Article, with publication-date metadata of 1997 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Emideltide

Circadian variation of DSIP-like material in rat plasma.

PubMed lists PMID 6548540 in Life sciences as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-11-12 (day precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

June 2019

27 records on this page

Literature metadata · Gonadorelin

Identification of gonadorelin (LHRH) derivatives: comparison of reversed-phase high-performance liquid chromatography and micellar electrokinetic chromatography.

PubMed lists PMID 8491839 in Journal of chromatography as Comparative Study, Journal Article, with publication-date metadata of 1993-04-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Melanotan II

High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma.

PubMed lists PMID 1336500 in Journal of chromatography as Journal Article, with publication-date metadata of 1992-12-23 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin alpha-1

Serum thymosin alpha 1 levels in normal and pathological conditions.

PubMed lists PMID 30063864 in Expert opinion on biological therapy as Journal Article, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin alpha-1

Thymosin alpha 1 treatment for patients with sepsis.

PubMed lists PMID 30063866 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Bremelanotide

Drugs@FDA application NDA210557

The official Drugs@FDA dataset lists original submission 1 for NDA 210557 with status AP dated 2019-06-21, and names bremelanotide acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Literature metadata · Calcitonin salmon

Salmon calcitonin in the treatment of postmenopausal osteoporosis.

PubMed lists PMID 3318613 in Annals of internal medicine as Journal Article, Review, with publication-date metadata of 1987-12 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 12851303

PeptideScanner retained PubMed bibliographic metadata for PMID 12851303 at 2026-07-30T20:51:53.921Z. PubMed recorded a metadata revision date of 2019-06-16 and an Entrez history date of 2003-07-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Nafarelin in the management of endometriosis: quality of life assessment.

PubMed lists PMID 1531576 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1992-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Nafarelin in the treatment of pelvic pain caused by endometriosis.

PubMed lists PMID 2137972 in American journal of obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Comparison of the pharmacology of nafarelin and danazol.

PubMed lists PMID 2137975 in American journal of obstetrics and gynecology as Comparative Study, Journal Article, Review, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Nafarelin versus danazol in the treatment of endometriosis.

PubMed lists PMID 2137976 in American journal of obstetrics and gynecology as Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1990-02 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome.

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Plecanatide

PubMed record PMID 29343131

PeptideScanner retained PubMed bibliographic metadata for PMID 29343131 at 2026-07-30T20:51:54.923Z. PubMed recorded a metadata revision date of 2019-06-13 and an Entrez history date of 2018-01-19. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Semax

N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes.

PubMed lists PMID 1851003 in Biochemical and biophysical research communications as Journal Article, with publication-date metadata of 1991-04-30 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Severe hyperkalaemia with nafarelin.

PubMed lists PMID 8569395 in Lancet (London, England) as Case Reports, Letter, with publication-date metadata of 1996-02-03 (day precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

May 2019

25 records on this page

Literature metadata · Desmopressin

Desmopressin (Nocdurna and Noctiva) for nocturnal polyuria.

PubMed lists PMID 31022158 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2019-03-25 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Leuprolide

Federal Register notice 2019-11243

The Federal Register published notice 2019-11243, attributed to FDA and its parent HHS department, on 2019-05-30. Its official title is “Determination That LUPRON (Leuprolide Acetate) Injection, 1 Milligram/0.2 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Etelcalcetide

Parsabiv Could Be Pricey Addition In Care for CKD, ESRD Patients.

PubMed lists PMID 28661841 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2017-06 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Desmopressin

Federal Register notice 2019-10165

The Federal Register published notice 2019-10165, attributed to FDA and its parent HHS department, on 2019-05-16. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Nafarelin

Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.

PubMed lists PMID 11495415 in Journal of assisted reproduction and genetics as Case Reports, Journal Article, with publication-date metadata of 2001-06 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.

PubMed lists PMID 12562683 in The Journal of antimicrobial chemotherapy as Journal Article, Review, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.

PubMed lists PMID 10099998 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

The LHRH antagonist cetrorelix: a review.

PubMed lists PMID 10972520 in Human reproduction update as Journal Article, Review, with publication-date metadata of 2000 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

PubMed lists PMID 12151431 in Human reproduction (Oxford, England) as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2002-08 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.

PubMed lists PMID 9363724 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, with publication-date metadata of 1997-09 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cetrorelix

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.

PubMed lists PMID 9688409 in Human reproduction (Oxford, England) as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1998-06 (month precision). PeptideScanner associated the retained record with the identity slug cetrorelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.

PubMed lists PMID 2970910 in Clinical pharmacology and therapeutics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 1988-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Cerebrolysin: a multi-target drug for recovery after stroke.

PubMed lists PMID 30004268 in Expert review of neurotherapeutics as Journal Article, Review, with publication-date metadata of 2018-07-18 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 27859635

PeptideScanner retained PubMed bibliographic metadata for PMID 27859635 at 2026-07-30T20:53:23.986Z. PubMed recorded a metadata revision date of 2019-05-09 and an Entrez history date of 2016-11-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Dalbavancin

Federal Register notice 2019-09007

The Federal Register published notice 2019-09007, attributed to FDA and its parent HHS department, on 2019-05-03. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Dalbavancin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Secretin

Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions.

PubMed lists PMID 12876178 in Archives of disease in childhood as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 2003-08 (month precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.

PubMed lists PMID 1329673 in Archives of disease in childhood as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1992-09 (month precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

April 2019

9 records on this page

Literature metadata · GHK-Cu

PubMed record PMID 29986520

PeptideScanner retained PubMed bibliographic metadata for PMID 29986520 at 2026-07-30T20:54:32.100Z. PubMed recorded a metadata revision date of 2019-04-24 and an Entrez history date of 2018-07-11. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Efinopegdutide

ClinicalTrials.gov record NCT03586843

PeptideScanner retained ClinicalTrials.gov record NCT03586843 at 2026-11-16T17:46:45.897Z. Its registry update date was 2019-04-16, and PeptideScanner's reviewed identity mapping was efinopegdutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT01785875

PeptideScanner retained ClinicalTrials.gov record NCT01785875 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-04-10, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02239523

PeptideScanner retained ClinicalTrials.gov record NCT02239523 at 2026-07-30T20:53:39.666Z. Its registry update date was 2019-04-05, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT02883595

PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Regulatory · Daptomycin

Federal Register notice 2019-06385

The Federal Register published notice 2019-06385, attributed to FDA and its parent HHS department, on 2019-04-02. Its official title is “Post-Marketing Pediatric-Focused Product Safety Reviews; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Glatiramer acetate

Glatiramer Acetate: from Bench to Bed and Back.

PubMed lists PMID 30905097 in The Israel Medical Association journal : IMAJ as Journal Article, Review, with publication-date metadata of 2019-03 (month precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

March 2019

15 records on this page

Literature metadata · Desmopressin

Desmopressin for treating nocturia in men.

PubMed lists PMID 29489052 in BJU international as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2018-03-26 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 29800372

PeptideScanner retained PubMed bibliographic metadata for PMID 29800372 at 2026-07-30T20:55:52.341Z. PubMed recorded a metadata revision date of 2019-03-26 and an Entrez history date of 2018-05-26. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Plecanatide

PubMed record PMID 28506401

PeptideScanner retained PubMed bibliographic metadata for PMID 28506401 at 2026-07-30T20:55:52.312Z. PubMed recorded a metadata revision date of 2019-03-20 and an Entrez history date of 2017-05-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Linaclotide for the treatment of chronic constipation.

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 28189361

PeptideScanner retained PubMed bibliographic metadata for PMID 28189361 at 2026-07-30T20:55:52.311Z. PubMed recorded a metadata revision date of 2019-03-18 and an Entrez history date of 2017-02-13. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Peginesatide

ClinicalTrials.gov record NCT00314795

PeptideScanner retained ClinicalTrials.gov record NCT00314795 at 2026-11-16T17:45:11.119Z. Its registry update date was 2019-03-14, and PeptideScanner's reviewed identity mapping was peginesatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Melanotan II

The unregulated use of melanotan-II is of public health interest to Australian dermatologists.

PubMed lists PMID 28905366 in The Australasian journal of dermatology as Case Reports, Letter, with publication-date metadata of 2017-09-14 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Oxytocin

Federal Register rule 2019-04226

The Federal Register published rule 2019-04226, attributed to FDA and its parent HHS department, on 2019-03-13. Its official title is “New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Changes of Sponsorship,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

Regulatory · Vasopressin

Federal Register notice 2019-03810

The Federal Register published notice 2019-03810, attributed to FDA and its parent HHS department, on 2019-03-04. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

February 2019

15 records on this page

Regulatory · Daptomycin

Federal Register notice 2019-03129

The Federal Register published notice 2019-03129, attributed to FDA and its parent HHS department, on 2019-02-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 29260289

PeptideScanner retained PubMed bibliographic metadata for PMID 29260289 at 2026-07-30T20:57:06.138Z. PubMed recorded a metadata revision date of 2019-02-25 and an Entrez history date of 2017-12-21. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Nesiritide

Intermittent nesiritide therapy in outpatients with chronic heart failure.

PubMed lists PMID 15700894 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2005-01-15 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin alpha-1

Thymosin alpha-1.

PubMed lists PMID 11381492 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, Review, with publication-date metadata of 2001-05-15 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

Properties of pramlintide and insulin upon mixing.

PubMed lists PMID 15821274 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-04-15 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.

PubMed lists PMID 29155000 in The spine journal : official journal of the North American Spine Society as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017-11-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Ganirelix

Ganirelix acetate.

PubMed lists PMID 10582819 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 1999-11-15 (day precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

Triptorelin depot for the treatment of children 2 years and older with central precocious puberty.

PubMed lists PMID 29957076 in Expert review of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 29910025

PeptideScanner retained PubMed bibliographic metadata for PMID 29910025 at 2026-07-30T20:57:06.150Z. PubMed recorded a metadata revision date of 2019-02-21 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Vasopressin

ClinicalTrials.gov record NCT01318278

PeptideScanner retained ClinicalTrials.gov record NCT01318278 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-02-20, and PeptideScanner's reviewed identity mapping was vasopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pasireotide

Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.

PubMed lists PMID 29534939 in Clinical genitourinary cancer as Clinical Trial, Phase I, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-02-13 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT00765999

PeptideScanner retained ClinicalTrials.gov record NCT00765999 at 2026-07-30T20:56:08.251Z. Its registry update date was 2019-02-15, and PeptideScanner's reviewed identity mapping was linaclotide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Desmopressin

Drugs@FDA application ANDA091374

The official Drugs@FDA dataset lists original submission 1 for ANDA 091374 with status AP dated 2019-02-14, and names desmopressin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Regulatory · Peginesatide

Federal Register notice 2019-02146

The Federal Register published notice 2019-02146, attributed to FDA and its parent HHS department, on 2019-02-13. Its official title is “Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT02584231

PeptideScanner retained ClinicalTrials.gov record NCT02584231 at 2026-11-16T01:33:21.554Z. Its registry update date was 2019-02-06, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

January 2019

17 records on this page

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT03824002

PeptideScanner retained ClinicalTrials.gov record NCT03824002 at 2026-07-30T20:57:18.709Z. Its registry update date was 2019-01-31, and PeptideScanner's reviewed identity mapping was dulaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Mecasermin

Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.

PubMed lists PMID 29695048 in International journal of molecular sciences as Case Reports, Journal Article, Review, with publication-date metadata of 2018-04-24 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin alpha-1

Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study.

PubMed lists PMID 30063860 in Expert opinion on biological therapy as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02472782

PeptideScanner retained ClinicalTrials.gov record NCT02472782 at 2026-07-30T20:57:18.711Z. Its registry update date was 2019-01-10, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pasireotide

Insulin sensitivity and secretion and adipokine profile in patients with Cushing's disease treated with pasireotide.

PubMed lists PMID 29396758 in Journal of endocrinological investigation as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-02-02 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · PEG-MGF

Mechano-growth factor accelerates the proliferation and osteogenic differentiation of rabbit mesenchymal stem cells through the PI3K/AKT pathway.

PubMed lists PMID 25588515 in BMC biochemistry as Journal Article, with publication-date metadata of 2015-01-15 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Dalbavancin

ClinicalTrials.gov record NCT02685033

PeptideScanner retained ClinicalTrials.gov record NCT02685033 at 2026-11-16T17:37:42.807Z. Its registry update date was 2019-01-04, and PeptideScanner's reviewed identity mapping was dalbavancin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 29852875

PeptideScanner retained PubMed bibliographic metadata for PMID 29852875 at 2026-07-30T20:58:13.922Z. PubMed recorded a metadata revision date of 2019-01-03 and an Entrez history date of 2018-06-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Aviptadil

Aviptadil (Senatek).

PubMed lists PMID 11566015 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2001-04 (month precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Aviptadil

Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS.

PubMed lists PMID 24176753 in Journal of pharmaceutical and biomedical analysis as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-10-05 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Experts recommend against calcitonin-salmon for postmenopausal osteoporosis.

PubMed lists PMID 23552038 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as News, with publication-date metadata of 2013-04-15 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→